Hydralazine Hydrochloride Tablet
Product Images NDC 51079-075

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 51079-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Hydralazine Hydrochloride Tablet 089097 088467 088 1

Hydralazine Hydrochloride Tablet 089097 088467 088 1
FDA Label Image

Chem Structure (Image 01)

Chem Structure (Image 01)
Hydralazine Hydrochloride Tablets, USP with NDC number 51079-074-20 is a medication used to treat high blood pressure. The dosage and other details are not available in the text. It is manufactured by Mylan pharmaceutical company.*
FDA Label Image

Hydralazine Hydrochloride 10 mg Tablets Unit Carton Label (Image 02)

Hydralazine Hydrochloride 10 mg Tablets Unit Carton Label (Image 02)
FDA Label Image

Hydralazine Hydrochloride 25 mg Tablets Unit Carton Label (Image 03)

Hydralazine Hydrochloride 25 mg Tablets Unit Carton Label (Image 03)
FDA Label Image

Unit Carton (Image 04)

Unit Carton (Image 04)
FDA Label Image

Hydralazine Hydrochloride 50 mg Tablets Unit Carton Label (Image 05)

Hydralazine Hydrochloride 50 mg Tablets Unit Carton Label (Image 05)
FDA Label Image

Unit Carton (Image 06)

Unit Carton (Image 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.